109 related articles for article (PubMed ID: 38874035)
1. Multitargeted Docking, DFT-Based Optimisation, Pharmacokinetics, and MD Simulation Reveal 6-Oxidopamine HBr as a Multitargeted Inhibitor of Cervical Cancer Proteins.
Alghamdi YS; Mashraqi MM; Alsalmi O; Alharthi AA; Gharib AF
Curr Med Chem; 2024 Jun; ():. PubMed ID: 38874035
[TBL] [Abstract][Full Text] [Related]
2. Delineating Pixantrone Maleate's adroit activity against cervical cancer proteins through multitargeted docking-based MM\GBSA, QM-DFT and MD simulation.
Almasoudi HH; Nahari MH; Alhazmi AYM; Almasabi SHA; Al-Mansour FSH; Hakami MA
PLoS One; 2023; 18(12):e0295714. PubMed ID: 38100507
[TBL] [Abstract][Full Text] [Related]
3. Multitargeted inhibitory effect of Mitoxantrone 2HCl on cervical cancer cell cycle regulatory proteins: a multitargeted docking-based MM\GBSA and MD simulation study.
Alshehri MA; Asiri SA; Alzahrani A; Alazragi RS; Alqahtani LS; Alqosaibi AI; Alnamshan MM; Alam Q; Rafeeq MM
Med Oncol; 2023 Oct; 40(11):337. PubMed ID: 37864019
[TBL] [Abstract][Full Text] [Related]
4. Structure-based multitargeted docking screening, pharmacokinetics, DFT, and dynamics simulation studies reveal mitoglitazone as a potent inhibitor of cellular survival and stress response proteins of lung cancer.
Binshaya AS; Alkahtani OS; Aldakheel FM; Hjazi A; Almasoudi HH
Med Oncol; 2024 Mar; 41(5):101. PubMed ID: 38546811
[TBL] [Abstract][Full Text] [Related]
5. Unveiling the multitargeted repurposing potential of taxifolin (dihydroquercetin) in cervical cancer: an extensive MM\GBSA-based screening, and MD simulation study.
Almasoudi HH; Hakami MA; Alhazmi AY; Makkawi M; Alasmari S; Alghamdi YS; Mashraqi MM
Med Oncol; 2023 Jul; 40(8):218. PubMed ID: 37394519
[TBL] [Abstract][Full Text] [Related]
6. Mitoxantrone 2HCl's adroit activity against cervical cancer replication and maintenance proteins: a multitargeted approach.
Hakami MA; Hazazi A; Alsulami MO; Alsaiari AA
J Biomol Struct Dyn; 2024 Mar; ():1-14. PubMed ID: 38517073
[TBL] [Abstract][Full Text] [Related]
7. Delineated 3-1-BenCarMethInYlPro-Phosphonic Acid's Adroit Activity against Lung Cancer through Multitargeted Docking, MM\GBSA, QM-DFT and Multiscale Simulations.
Hakami MA; Hazazi A; Albloui F; Gharib AF; Alsaeedi FA; Abdulaziz O; Alhazmi AY; Alsaiari AA
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203761
[TBL] [Abstract][Full Text] [Related]
8. Unrevealing the multitargeted potency of 3-1-BCMIYPPA against lung cancer structural maintenance and suppression proteins through pharmacokinetics, QM-DFT, and multiscale MD simulation studies.
Alshehri MA; Asiri SA; Helmi N; Baeissa HM; Hamadi A; Alzahrani A; Alghamdi RM; Rafeeq MM; Alharbi ZM; Kamal MA
PLoS One; 2024; 19(6):e0303784. PubMed ID: 38905286
[TBL] [Abstract][Full Text] [Related]
9. Identification of 5-nitroindazole as a multitargeted inhibitor for CDK and transferase kinase in lung cancer: a multisampling algorithm-based structural study.
Ahmad S; Raza K
Mol Divers; 2023 Apr; ():. PubMed ID: 37058176
[TBL] [Abstract][Full Text] [Related]
10. Unveiling the multitargeted potency of Sodium Danshensu against cervical cancer: a multitargeted docking-based, structural fingerprinting and molecular dynamics simulation study.
Alghamdi S; Baeissa HM; Azhar Kamal M; Rafeeq MM; Al Zahrani A; Maslum AA; Hakeem IJ; Alazragi RS; Alam Q
J Biomol Struct Dyn; 2023 Aug; ():1-13. PubMed ID: 37599470
[TBL] [Abstract][Full Text] [Related]
11. Multisampling-based docking reveals Imidazolidinyl urea as a multitargeted inhibitor for lung cancer: an optimisation followed multi-simulation and
Ahmad S; Singh V; Gautam HK; Raza K
J Biomol Struct Dyn; 2024 Mar; 42(5):2494-2511. PubMed ID: 37154501
[TBL] [Abstract][Full Text] [Related]
12. Chlordiazepoxide against signalling, receptor and regulatory proteins of breast cancer: a structure-based in-silico approach.
Alsaiari AA; Gharib AF; Bakhuraysah MM; Alrehaili AA; Algethami SM; Alsaif HA; Al Harthi N; Hakami MA
Med Oncol; 2024 Apr; 41(5):117. PubMed ID: 38630325
[TBL] [Abstract][Full Text] [Related]
13. Structure-Based In Silico Approaches Reveal IRESSA as a Multitargeted Breast Cancer Regulatory, Signalling, and Receptor Protein Inhibitor.
Almasoudi HH; Mashraqi MM; Alshamrani SA; Alharthi AA; Alsalmi O; Nahari MH; Al-Mansour FSH; Alhazmi AYM
Pharmaceuticals (Basel); 2024 Feb; 17(2):. PubMed ID: 38399423
[TBL] [Abstract][Full Text] [Related]
14. Variolin B from sea sponge against lung cancer: a multitargeted molecular docking with fingerprinting and molecular dynamics simulation study.
Alsalmi O; Mashraqi MM; Alshamrani S; Almasoudi HH; Alharthi AA; Gharib AF
J Biomol Struct Dyn; 2024 Apr; 42(7):3507-3519. PubMed ID: 37855303
[TBL] [Abstract][Full Text] [Related]
15. Molecular screening reveals Variolin B as a multitargeted inhibitor of lung cancer: a molecular docking-based fingerprinting and molecular dynamics simulation study.
Almasoudi HH; Mashraqi MM; Alshamrani S; Alsalmi O; Alharthi AA; Gharib AF
J Biomol Struct Dyn; 2024; 42(1):11-21. PubMed ID: 37771142
[TBL] [Abstract][Full Text] [Related]
16. Integrative analysis discovers Imidurea as dual multitargeted inhibitor of CD69, CD40, SHP2, lysozyme, GATA3, cCBL, and S-cysteinase from SARS-CoV-2 and M. tuberculosis.
Ahmad S; Singh AP; Bano N; Raza K; Singh J; Medigeshi GR; Pandey R; Gautam HK
Int J Biol Macromol; 2024 Jun; 270(Pt 2):132332. PubMed ID: 38768914
[TBL] [Abstract][Full Text] [Related]
17. In-silico analysis reveals Quinic acid as a multitargeted inhibitor against Cervical Cancer.
Ahmad S; Sayeed S; Bano N; Sheikh K; Raza K
J Biomol Struct Dyn; 2023 Nov; 41(19):9770-9786. PubMed ID: 36379678
[TBL] [Abstract][Full Text] [Related]
18. Molecular docking, ADMET and molecular dynamics simulation revealed metralindole as a multitargeted inhibitor for division kinases.
Al-Dhuayan I; ALaqeel NK
Braz J Biol; 2023; 83():e271688. PubMed ID: 37075433
[TBL] [Abstract][Full Text] [Related]
19. Repurposing of approved drugs for targeting CDK4/6 and aromatase protein using molecular docking and molecular dynamics studies.
Yousif FA; Alzain AA; Alraih AM; Ibraheem W
PLoS One; 2023; 18(9):e0291256. PubMed ID: 37682937
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory Effects.
Elkaeed EB; Yousef RG; Elkady H; Gobaara IMM; Alsfouk BA; Husein DZ; Ibrahim IM; Metwaly AM; Eissa IH
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
